Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and equivalents	$ 27,600	$ 17,957
Accounts receivable, net	254,682	155,273
Inventories	165,950	110,683
Deferred income taxes	5,311	1,813
Prepaid expenses and other current assets	7,427	5,360
Total current assets	460,970	291,086
Property and equipment, net	16,538	13,150
Capitalized software for internal use, net	37,250	13,236
Goodwill	256,318	23,148
Definite-lived intangible assets, net	224,644	44,973
Investment in non-consolidated entity	4,959	3,500
Deferred debt issuance costs	5,013	921
Other noncurrent assets	181	72
Total assets	1,005,873	390,086
Current liabilities:
Accounts payable	296,587	202,495
Short-term debt, including current portion of long-term debt	6,000
Accrued expenses:
Contingent consideration	52,665	6,282
Compensation and benefits	5,563	2,257
Other	11,087	4,394
Total current liabilities	371,902	215,428
Contingent consideration, less current portion	111,000
Contingent consideration liability		5,409
Deferred income taxes	7,425	518
Other noncurrent liabilities		4
Total liabilities	$ 490,327	$ 221,359
Commitments and contingencies
Shareholders' equity:
Preferred stock (10,000,000 shares authorized; none issued and outstanding)
Common stock:
Common stock (no par value; 590,000,000 shares authorized; 64,523,864 and 51,457,023 shares issued and outstanding at December 31, 2015 and December 31, 2014, respectively)	$ 451,620	$ 148,901
Additional paid-in capital	29,221	9,893
Retained earnings	31,130	5,354
Total Diplomat Pharmacy shareholders' equity	511,971	164,148
Noncontrolling interests	3,575	4,579
Total shareholders' equity	515,546	168,727
Total liabilities and shareholders' equity	$ 1,005,873	$ 390,086